Tamagnone, Luca
 Distribuzione geografica
Continente #
NA - Nord America 3.575
AS - Asia 3.476
EU - Europa 2.355
SA - Sud America 1.055
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 10.554
Nazione #
US - Stati Uniti d'America 3.446
SG - Singapore 1.541
BR - Brasile 885
CN - Cina 681
SE - Svezia 681
VN - Vietnam 464
FR - Francia 381
IT - Italia 374
IE - Irlanda 350
DE - Germania 147
ID - Indonesia 137
IN - India 118
JP - Giappone 112
GB - Regno Unito 103
HK - Hong Kong 100
AR - Argentina 66
RU - Federazione Russa 65
CA - Canada 63
FI - Finlandia 57
BD - Bangladesh 50
IQ - Iraq 49
MX - Messico 37
TR - Turchia 36
NL - Olanda 31
PL - Polonia 30
EC - Ecuador 29
IL - Israele 29
UA - Ucraina 29
AT - Austria 23
ES - Italia 20
PK - Pakistan 20
ZA - Sudafrica 20
CO - Colombia 17
MA - Marocco 17
CZ - Repubblica Ceca 16
KR - Corea 16
PY - Paraguay 16
VE - Venezuela 16
MY - Malesia 15
UZ - Uzbekistan 15
SA - Arabia Saudita 14
CL - Cile 11
DZ - Algeria 10
IR - Iran 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
AZ - Azerbaigian 7
BG - Bulgaria 7
CH - Svizzera 7
EG - Egitto 7
HN - Honduras 6
PE - Perù 6
RO - Romania 6
TW - Taiwan 6
EU - Europa 5
JO - Giordania 5
OM - Oman 5
PH - Filippine 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BE - Belgio 4
CR - Costa Rica 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
AM - Armenia 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 10.544
Città #
Singapore 643
Menlo Park 532
San Jose 455
Ashburn 423
Beijing 210
Dublin 184
Ho Chi Minh City 167
Chandler 149
Jakarta 117
Hanoi 113
Lauterbourg 110
Milan 105
Princeton 104
Tokyo 98
Hong Kong 87
Los Angeles 84
Wilmington 78
Cattolica 76
San Mateo 72
São Paulo 72
Council Bluffs 71
New York 66
Redwood City 65
Boston 57
Rome 57
Dearborn 56
Frankfurt am Main 48
Hefei 45
Chicago 44
Dallas 44
Hyderabad 39
Santa Clara 37
Helsinki 34
Moscow 31
Rio de Janeiro 28
Munich 26
Nanjing 26
Norwalk 24
The Dalles 24
Brooklyn 23
Haiphong 23
Warsaw 23
Paris 22
Washington 22
Hangzhou 21
Da Nang 20
Seattle 18
Shanghai 18
St Louis 18
Toronto 18
Fairfield 17
Porto Alegre 17
Montreal 16
Buffalo 15
Guangzhou 15
Houston 15
Baghdad 14
Curitiba 14
Nuremberg 14
Andover 13
Brasília 13
Lappeenranta 13
London 13
Tashkent 13
Dhaka 12
Mountain View 12
Orem 12
Tel Aviv 12
Chennai 11
Jacksonville 11
Johannesburg 11
Kent 11
Mexico City 11
Seoul 11
Atlanta 10
Belo Horizonte 10
Manchester 10
Nanchang 10
Ninh Bình 10
Phoenix 10
Puchong Batu Dua Belas 10
Quito 10
Tianjin 10
Turin 10
Turku 10
Vienna 10
Woodbridge 10
Ankara 9
Asunción 9
Buenos Aires 9
Calgary 9
Nairobi 9
Stockholm 9
Amsterdam 8
Ann Arbor 8
Bogotá 8
Busto Arsizio 8
Changsha 8
Lahore 8
Mumbai 8
Totale 5.483
Nome #
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups 941
Endothelial Cell Metabolism in Vascular Functions 208
Semaphorins: Missing Signals in Age-dependent Alteration of Neuromuscular Junctions and Skeletal Muscle Regeneration 167
Taurine Administration Counteracts Aging-Associated Impingement of Skeletal Muscle Regeneration by Reducing Inflammation and Oxidative Stress 153
SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth 137
LPHN2 inhibits vascular permeability by differential control of endothelial cell adhesion 134
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE 132
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer 125
A prognostic model for melanoma patients on the basis of immune-related lncRNAs 124
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 124
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 122
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development 121
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML. 120
PlexinA4 mediates cytotoxic T cell trafficking and exclusion in cancer 117
Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1 116
NOVEL MEMBERS OF THE PLEXIN FAMILY AND USES THEREOF 115
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development. 113
Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells 109
Plexin‑Bs enhance their GAP activity with a novel activation switch loop generating a cooperative enzyme. 109
Message in a Bottle: Endothelial Cell Regulation by Extracellular Vesicles 108
Neuropilin1-dependent paracrine signaling of cancer cells mediated by miRNA exosomal cargo 107
Antibody-Feeding Assay: A Method to Track the Internalization of Neuropilin-1 and Other Cell Surface Receptors 107
Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma 107
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells 105
Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress 104
Semaphorins in health and disease 100
Neuropilins Controlling Cancer Therapy Responsiveness 99
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. 99
Taming the Notch Transcriptional Regulator for Cancer Therapy 96
Transmembrane semaphorins: Multimodal signaling cues in development and cancer 95
To Die or Not to Die: Sema3E Rules the Game 95
RETINOIC ACID AND PROTEOTOXIC STRESS INDUCE AML CELL DEATH OVERCOMING STROMAL CELL PRTOTECTION 94
Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer 94
PlexinB1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic dissemination 93
Rhomboid-Like-2 Intramembrane Protease Mediates Metalloprotease-Independent Regulation of Cadherins 93
Transmembrane semaphorins, forward and reverse signaling: Have a look both ways 92
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies 92
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study 90
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer 89
The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth 89
Glia–glia crosstalk via semaphorins: Emerging implications in neurodegeneration 86
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages 86
Bad vessels beware! Semaphorins will sort you out! 85
Semaphorin Signaling in Cancer-Associated Inflammation. 85
Targetin Semaphorin 4D in Cancer: A Look from Different Perspectives 84
Semaphorin Signals on the Road of Endothelial Tip Cells 84
Signalling by semaphorin receptors: Cell guidance and beyond 83
Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis 83
Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene 82
Semaphorin signals on the road to cancer invasion and metastasis 82
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development 82
To move or not to move? Semaphorin signalling in cell migration 80
Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression 80
Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential 80
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 80
Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive 79
Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence. 79
Enviromental maternal exposures and the risk of premature birth and intrauterine growth restriction: The Generation Gemelli study protocol of newborn exposome 78
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 77
Hemodialysis stimulates hepatocyte growth factor release 77
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts 77
Semaphorins and Their Receptors in Hematological Malignancies. 77
Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms 76
The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways. 76
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function 75
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - Two sides of a coin 75
Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells. 74
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway 73
Structure and function of the intracellular region of the plexin-B1 transmembrane receptor 73
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 73
Plasminogen-related growth factor and semaphorin receptors: A gene superfamily controlling invasive growth 73
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2 73
The transmembrane protein off-track associates with plexins and functions downstream of semaphorin signaling during axon guidance 72
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury 70
Semaphorins in cancer: Biological mechanisms and therapeutic approaches 70
Semaphorin pathways orchestrate osteogenesis 69
Downregulating neuropilin-2 triggers a novel mechanism enabling EGFR-dependent resistance to oncogene-targeted therapies 69
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function 69
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling 68
Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney 67
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival 67
Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively 66
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment 66
Invasive growth: A two-way street for semaphorin signalling 66
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 66
The human ryk cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain 65
Sema4D induces angiogenesis through Met recruitment by Plexin B1 65
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice 65
Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis 64
Plexin A is a neuronal semaphorin receptor that controls axon guidance 64
PlexinD1 is a novel transcriptional target and effector of notch signaling in cancer cells 64
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer 64
Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models 64
The semaphorin 4D receptor controls invasive growth by coupling with Met 62
Experimental approaches for studying semaphorin signals in tumor growth and metastasis in mouse models 61
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity 61
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor 61
Semaphorin Signals Tweaking the Tumor Microenvironment 60
Functional regulation of semaphorin receptors by proprotein convertases 59
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line 59
Totale 9.685
Categoria #
all - tutte 51.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 29 26 17
2021/20221.413 73 3 780 62 59 25 24 111 29 31 118 98
2022/20231.086 156 239 146 45 68 134 27 117 73 24 39 18
2023/2024947 21 235 100 30 51 158 43 39 11 26 97 136
2024/20251.727 35 15 142 52 77 71 67 81 248 190 443 306
2025/20264.750 805 294 372 706 556 196 815 242 401 363 0 0
Totale 10.807